Ignite Creation Date:
2025-12-25 @ 5:05 AM
Ignite Modification Date:
2026-02-11 @ 11:25 AM
Study NCT ID:
NCT02235727
Status:
COMPLETED
Last Update Posted:
2017-01-24
First Post:
2014-08-07
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Safety and Tolerability of GBR 900 in a Single Ascending Dose Study in Healthy Subjects
Sponsor:
Glenmark Pharmaceuticals Ltd. India
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
GBR 900-101
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |